Literature DB >> 18711406

Management of recurrent and refractory Cushing disease.

Manish K Aghi1.   

Abstract

Cushing disease is most frequently caused by pituitary adenomas that secrete adrenocorticotrophic hormone. Transsphenoidal surgery is the treatment of choice in patients with these tumors because of reported remission rates of 69-93%. More challenging for neurosurgeons and endocrinologists, however, is management of the remaining patients whose Cushing disease is refractory to initial transsphenoidal surgery or recurs after initial remission. Here, we review the treatment options and latest surgical, medical, and radiosurgical advances for patients who have persistent or recurrent Cushing disease after transsphenoidal surgery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18711406     DOI: 10.1038/ncpendmet0947

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN: 1745-8366


  11 in total

Review 1.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

Review 2.  Up-to 5-year efficacy of pasireotide in a patient with Cushing's disease and pre-existing diabetes: literature review and clinical practice considerations.

Authors:  Laura Trementino; Marina Cardinaletti; Carolina Concettoni; Giorgia Marcelli; Marco Boscaro; Giorgio Arnaldi
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

Review 3.  Approach to the postoperative patient with Cushing's disease.

Authors:  Martin J Rutkowski; Jonathan D Breshears; Sandeep Kunwar; Manish K Aghi; Lewis S Blevins
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

Review 4.  Surgical and radiosurgical treatment strategies for Cushing's disease.

Authors:  Adomas Bunevicius; Edward R Laws; Mary Lee Vance; Sherry Iuliano; Jason Sheehan
Journal:  J Neurooncol       Date:  2019-11-01       Impact factor: 4.130

5.  Downregulation of Insulin-like growth factor binding protein 6 is associated with ACTH-secreting pituitary adenoma growth.

Authors:  Yakun Yang; Miaomiao Sheng; Fengming Huang; Dechao Bu; Xiaohai Liu; Yong Yao; Congxin Dai; Bowen Sun; Jindong Zhu; Yonghui Jiao; Zhenqing Wei; Huijuan Zhu; Lin Lu; Yi Zhao; Chengyu Jiang; Renzhi Wang
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

6.  Pituitary tumors.

Authors:  Nestoras Mathioudakis; Roberto Salvatori
Journal:  Curr Treat Options Neurol       Date:  2009-07       Impact factor: 3.598

Review 7.  Cushing's disease.

Authors:  Frederic Castinetti; Isabelle Morange; Bernard Conte-Devolx; Thierry Brue
Journal:  Orphanet J Rare Dis       Date:  2012-06-18       Impact factor: 4.123

8.  ICA Occlusion by an ACTH-secreting pituitary adenoma post-TSS and irradiation.

Authors:  Diala El-Zammar; Ryojo Akagami
Journal:  Mcgill J Med       Date:  2011-06

9.  Diagnosis and Multimodality Management of Cushing's Disease: A Practical Review.

Authors:  Gabriel Zada
Journal:  Int J Endocrinol       Date:  2013-01-15       Impact factor: 3.257

Review 10.  Dilated Cardiomyopathy Revealing Cushing Disease: A Case Report and Literature Review.

Authors:  Lucien Marchand; Bérénice Segrestin; Marion Lapoirie; Véronique Favrel; Julie Dementhon; Emmanuel Jouanneau; Gérald Raverot
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.